Flavonoids were shown to have antiproliferative and cell re-differentiation effects, inducing the re-expression of NIS mRNA in an anaplastic thyroid carcinoma cell line (FRO), suggesting that these compounds could be important as therapeutic agents in the treatment of thyroid cancer [100,101,102]. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.